Small cell lung cancer (SCLC) accounts for 20% of all lung cancers. More than two thirds of patients with SCLC present with clinically evident distant metastases. Patients with limited stage disease are treated with a combination of chemotherapy and chest radiation. Patients with extensive stage disease and good performance status are candidates for combination chemotherapy. Almost all patients relapse after an initial response. This article focuses on the common sense approach to the management of SCLC.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
small cell
8
cell lung
8
lung cancer
8
stage disease
8
combination chemotherapy
8
practical issues
4
issues management
4
management patient
4
patient small
4
cancer small
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!